Clinical Trial Results TV

Main Menu

Series

Duke Clinical Medicine
SCAI TV

Categories


	Duke Clinical Medicine: 235 submissions (showing 46 to 60)

| Page 1 | Page 2 | Page 3 | Page 4 | Page 5 | Page 6 | Page 7 | Page 8 | Page 9 | Page 10 | Page 11 | Page 12 | Page 13 | Page 14 | Page 15 | Page 16 |

FDA Universal Definitions Used in Clinical Trials to Adjudicate Events for Diabetes Trials
Dr. Kenneth Mahaffey, Dr. C. Michael Gibson

An Analysis from the EARLY-ACS Trial
Dr. Tracy Wang

Safety and Efficacy of Adjusted-Dose Eptifibatide in Patients With Acute Coronary Syndromes and Reduced Renal Function
Dr. Chiara Melloni

Rate of Obstructive Coronary Disease in Elective Diagnostic Cath
Dr. Manesh Patel

Dr. Harrington and Dr. Gibson discuss dronedarone, personalized medicine, and authorship issues concerning academic and
Dr. Robert Harrington, Dr. C. Michael Gibson

Dr. Daniel Mark and Dr. C. Michael Gibson discuss the STITCH trial
Dr. C. Michael Gibson, Dr. Daniel Mark

Dr. L. Kristin Newby, Dr. Robert Giugliano, and Dr. C. Michael Gibson discuss EARLY ACS
Dr. L. Kristin Newby, MD, Dr. Robert Giugliano, Dr. C. Michael Gibson

Dr. Manesh Patel and Dr. Chris Granger Discuss the OnTarget Trial
Dr. Christopher Granger, Dr. Manesh Patel

Dr. John Alexander and Dr. C. Michael Gibson discuss the results of the MEND-CABG II Trial.
Dr. C. Michael Gibson, Dr. John Alexander

Dr. John Alexander presents the main results of the MEND-CABG II Trial.
Dr. John Alexander

Dr. Adrian Hernandez Discusses the Influence of Age on the Management of Heart Failure
Dr. Adrian Hernandez, MD

Dr. Magnus Ohman Comments on The HORIZONS AMI Trial
Dr. Magnus Ohman

Dr. Robert Harrington and Dr. Sunil Rao discuss the interventional cardiology and preventative cardiology themes
Dr. Robert Harrington, Dr. Sunil Rao

The Future of Medical Communications - Copyleft
Dr. C. Michael Gibson, MD

Novel Concepts in ACS: Combining Antithrombotic and Bleeding Outcomes
Dr. Christopher Granger, MD